These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 9548473
1. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice. Van Parijs L, Sethna MP, Schweitzer AN, Borriello F, Sharpe AH, Abbas AK. J Immunol; 1997 Dec 01; 159(11):5336-44. PubMed ID: 9548473 [Abstract] [Full Text] [Related]
2. Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts. Pechhold K, Patterson NB, Craighead N, Lee KP, June CH, Harlan DM. J Immunol; 1997 May 15; 158(10):4921-9. PubMed ID: 9144510 [Abstract] [Full Text] [Related]
3. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle. Giguère JF, Bounou S, Paquette JS, Madrenas J, Tremblay MJ. J Virol; 2004 Jun 15; 78(12):6222-32. PubMed ID: 15163715 [Abstract] [Full Text] [Related]
4. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. Lenschow DJ, Sperling AI, Cooke MP, Freeman G, Rhee L, Decker DC, Gray G, Nadler LM, Goodnow CC, Bluestone JA. J Immunol; 1994 Sep 01; 153(5):1990-7. PubMed ID: 7519638 [Abstract] [Full Text] [Related]
5. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation. Trentin L, Perin A, Siviero M, Piazza F, Facco M, Gurrieri C, Galvan S, Adami F, Agostini C, Pizzolo G, Zambello R, Semenzato G. Cancer; 2000 Sep 15; 89(6):1259-68. PubMed ID: 11002221 [Abstract] [Full Text] [Related]
6. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H. Int Immunol; 2005 Jan 15; 17(1):73-83. PubMed ID: 15569772 [Abstract] [Full Text] [Related]
7. Time courses of B7 family molecules expressed on activated T-cells and their biological significance. Sun ZW, Qiu YH, Shi YJ, Tao R, Chen J, Ge Y, Hu YM, Ma HB, Shi Q, Zhang XG. Cell Immunol; 2005 Jan 15; 236(1-2):146-53. PubMed ID: 16165113 [Abstract] [Full Text] [Related]
8. B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. Roth R, Nakamura T, Mamula MJ. J Immunol; 1996 Oct 01; 157(7):2924-31. PubMed ID: 8816398 [Abstract] [Full Text] [Related]
12. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. Stack RM, Lenschow DJ, Gray GS, Bluestone JA, Fitch FW. J Immunol; 1994 Jun 15; 152(12):5723-33. PubMed ID: 7515912 [Abstract] [Full Text] [Related]
13. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Stopeck AT, Gessner A, Miller TP, Hersh EM, Johnson CS, Cui H, Frutiger Y, Grogan TM. Clin Cancer Res; 2000 Oct 15; 6(10):3904-9. PubMed ID: 11051236 [Abstract] [Full Text] [Related]